COMT Gene Catechol-o-methyltransferase deficiency Genetic Test
Test Name: COMT Gene Catechol-o-methyltransferase deficiency Genetic Test
Components: COMT gene
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for COMT Gene Catechol-o-methyltransferase deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Catechol-o-methyltransferase deficiency
Test Details: COMT gene, also known as catechol-O-methyltransferase, is responsible for producing an enzyme that helps in the breakdown of certain neurotransmitters, including dopamine, norepinephrine, and epinephrine. Genetic variations in the COMT gene can lead to differences in enzyme activity, which can affect neurotransmitter levels and function in the brain.
Catechol-O-methyltransferase deficiency is a condition characterized by reduced enzyme activity due to genetic variations in the COMT gene. This can result in altered neurotransmitter levels and function, leading to various symptoms and conditions.
Some common symptoms of COMT deficiency include:
- Cognitive and emotional symptoms: Individuals with COMT deficiency may experience difficulties with executive functions, such as working memory, attention, and cognitive flexibility. They may also have mood disorders, such as depression and anxiety.
- Pain sensitivity: COMT deficiency can also lead to increased pain sensitivity and a higher risk of chronic pain conditions.
- Impaired stress response: The altered neurotransmitter levels in individuals with COMT deficiency can affect the body’s stress response system, leading to difficulties in managing stress and increased vulnerability to stress-related disorders.
- Increased susceptibility to certain psychiatric disorders: Genetic variations in the COMT gene have been associated with an increased risk of developing certain psychiatric disorders, including schizophrenia and bipolar disorder.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for a comprehensive analysis of the entire COMT gene, including any variations or mutations that may be present.
NGS genetic testing can help in the diagnosis of COMT deficiency and provide information about an individual’s genetic predisposition to related symptoms and conditions. By identifying genetic variations in the COMT gene, NGS testing can help healthcare professionals tailor treatment plans and interventions to better manage symptoms and improve the quality of life for individuals with COMT deficiency.
Test Name | COMT Gene Catechol-o-methyltransferase deficiency Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for COMT Gene Catechol-o-methyltransferase deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Catechol-o-methyltransferase deficiency |
Test Details |
COMT gene, also known as catechol-O-methyltransferase, is responsible for producing an enzyme that helps in the breakdown of certain neurotransmitters, including dopamine, norepinephrine, and epinephrine. Genetic variations in the COMT gene can lead to differences in enzyme activity, which can affect neurotransmitter levels and function in the brain. Catechol-O-methyltransferase deficiency is a condition characterized by reduced enzyme activity due to genetic variations in the COMT gene. This can result in altered neurotransmitter levels and function, leading to various symptoms and conditions. Some common symptoms of COMT deficiency include: 1. Cognitive and emotional symptoms: Individuals with COMT deficiency may experience difficulties with executive functions, such as working memory, attention, and cognitive flexibility. They may also have mood disorders, such as depression and anxiety. 2. Pain sensitivity: COMT deficiency can also lead to increased pain sensitivity and a higher risk of chronic pain conditions. 3. Impaired stress response: The altered neurotransmitter levels in individuals with COMT deficiency can affect the body’s stress response system, leading to difficulties in managing stress and increased vulnerability to stress-related disorders. 4. Increased susceptibility to certain psychiatric disorders: Genetic variations in the COMT gene have been associated with an increased risk of developing certain psychiatric disorders, including schizophrenia and bipolar disorder. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. It allows for a comprehensive analysis of the entire COMT gene, including any variations or mutations that may be present. NGS genetic testing can help in the diagnosis of COMT deficiency and provide information about an individual’s genetic predisposition to related symptoms and conditions. By identifying genetic variations in the COMT gene, NGS testing can help healthcare professionals tailor treatment plans and interventions to better manage symptoms and improve the quality of life for individuals with COMT deficiency. |